excellence in private cancer care.

Creating trust in our care

We know the best methods of Controlling and Curing cancer

Our Oncology practice is based at Nottingham's premier private cancer treatment facilities.  We specialise in treatment of Prostate cancer, Kidney cancer, Bladder cancer, Ovarian cancer, & Cancers of Uterus and Cervix.

We provide High quality care tailored to your lifestyle and needs in a high quality, welcoming and friendly environment

We welcome both insured patients and patients paying for their own treatment. We accept patients registered with all insurers. We are happy to see patients for private follow up consultation only at the private hospital (with relevant blood tests done at GP surgery if appropriate).

We work with expert Surgeons, Urologists, Gynaecologists, Pathologists, Radiologists and other cancer specialists in screening for cancer.


Dr Sundar: Selected Publications

Upcoming Treatments

  • Immunotherapy would play an important role in treatment of all cancers in future.

  • PROVENGE® (sipuleucel-T) is approved by the FDA in USA  as an immunotherapy for the treatment metastatic (hormone refractory) prostate cancer. European Medicines Agency (EMA) will approve it shortly.

  • Genomic tumour assessment and molecular analysis of circulating tumour cells will result in personalised cancer treatment.

  • IMRT with IGRT is becoming standard of care for Prostate cancer.

Recent News

June 2013

Enzalutamide (Xtandi), a potent androgen receptor signalling inhibitor, which works by blocking the action of the male hormone testosterone, has been provided marketing authorisation by European Medicines agency for use in men with advanced metastatic prostate cancer.

July 2013

Radium 223, a alpha emitting novel radioisotope, has demonstrated excellent survival benefit in an international clinical trial (in which we were privileged to participate). This trial of more than 900 men with castration refractory prostate cancer was published in the prestigious New England Journal of Medicine.